RESULTS	Composite 24-month major adverse events were 39 % for the DCB group , including 15 target lesion revascularizations , 1 amputation , and 4 deaths versus 46 % for uncoated balloon group , with 20 target lesion revascularizations , 1 thrombosis , and 5 deaths .\